| 2024-06-11 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 2,831 0.004% | $22.64 | $64,094 | +0.3% | |
| 2024-03-13 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 724 0.0011% | $28.33 | $20,511 | -22.13% | |
| 2023-12-14 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 611 0.001% | $20.76 | $12,684 | -1.45% | |
| 2023-09-13 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 632 0.0011% | $50.34 | $31,815 | -56.72% | |
| 2023-06-20 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 20,777 0.0442% | $55.00 | $1.14M | -58.24% | |
| 2023-06-13 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 606 0.0013% | $55.16 | $33,427 | -59.3% | |
| 2023-01-23 | Sale | Ventyx Biosciences, Inc. VTYX | director | 33,353 0.0582% | $35.10 | $1.17M | -3.38% | |
| 2022-12-28 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 999 0.0021% | $49.76 | $49,714 | -9.81% | |
| 2022-10-13 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 20,000 0.0424% | $39.82 | $796,400 | +12% | |
| 2022-01-14 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 9,700 0.0274% | $22.03 | $213,691 | -32.41% | |
| 2021-12-21 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 100 0.0003% | $22.00 | $2,200 | -29.2% | |
| 2021-12-17 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 3,200 0.0096% | $22.04 | $70,528 | -28.6% | |
| 2021-11-01 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 6,500 0.018% | $22.24 | $144,560 | -34.18% | |
| 2021-10-01 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 6,500 0.0185% | $22.06 | $143,367 | -31.98% | |
| 2021-09-01 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 8,559 0.0244% | $24.00 | $205,416 | -34.84% | |
| 2021-08-02 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 4,441 0.0129% | $22.03 | $97,835 | -13.76% | |
| 2021-07-06 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 6,500 0.0185% | $24.52 | $159,380 | -19.05% | |
| 2021-05-03 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 4,200 0.0121% | $30.56 | $128,352 | -29.64% | |
| 2021-04-01 | Sale | Akero Therapeutics, Inc. AKRO | Chief Financial Officer | 100,000 0.2873% | $28.64 | $2.86M | -22.91% |